论文部分内容阅读
The effect of rosiglitazone on endocrine, metabolism and ovulatory performance in the paitents with polycystic ovary syndrome(PCOS) and insulin resistance was investigated. Twentyfive patients diagnosed as having polycystic ovary syndrome (PCOS) combined